BRAINLIFE.ORG





Neuro-Oncology Reviews




Volume 26 Number 9
15 May 2024




Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 9, 15 May






Morello A, Bianconi A, Rizzo F, Bellomo J, Meyer AC, Garbossa D, Regli L, Cofano F.
Laser Interstitial Thermotherapy (LITT) in Recurrent Glioblastoma: What Window of Opportunity for This Treatment?
Technol Cancer Res Treat. 2024 May 2;23:15330338241249026. doi: 10.1177/15330338241249026. PMID: 38693845. Review. ˍ




Ser MH, Webb MJ, Sener U, Campian JL.
Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions.
J Immunother Precis Oncol. 2024 May 2;7(2):97-110. doi: 10.36401/JIPO-23-34. PMID: 38721406. Review. ˍ




Akdemir EY, Odia Y, Hall MD, Mehta MP, Kotecha R.
An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice.
Pract Radiat Oncol. 2024 May 3:S1879-8500(24)00094-8. doi: 10.1016/j.prro.2024.04.013. PMID: 38704025. Guidelines˰ ˍ




Arfuso M, Kuril S, Shah H, Hanson D.
Pediatric Neuroglial Tumors: A Review of Ependymoma and Dysembryoplastic Neuroepithelial Tumor.
Pediatr Neurol. 2024 May 3;156:139-146. doi: 10.1016/j.pediatrneurol.2024.04.022. PMID: 38781722. Review˰ ˍ




Chesney KM, Keating GF, Patel N, Kilburn L, Fonseca A, Wu CC, Nazarian J, Packer RJ, Donoho DA, Oluigbo C, Myseros JS, Keating RF, Syed HR.
The role of focused ultrasound for pediatric brain tumors: current insights and future implications on treatment strategies.
Childs Nerv Syst. 2024 May 3. doi: 10.1007/s00381-024-06413-9. PMID: 38702518. Review˰ ˍ




Chou SC, Chen YN, Huang HY, Kuo MF, Wong TT, Kuo SH, Yang SH.
Contemporary Management of Pediatric Brainstem Tumors.
Adv Tech Stand Neurosurg. 2024 May 4;49:231-254. doi: 10.1007/978-3-031-42398-7_11. PMID: 38700687. Review; Book chapter˰ ˍ




Kotch C, de Blank P, Gutmann DH, Fisher MJ.
Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions.
Childs Nerv Syst. 2024 May 5. doi: 10.1007/s00381-024-06430-8. PMID: 38704493. Review˰ ˍ




Hu Z, Ye J, Shi S, Luo C, Wang T, Liu Y, Ye J, Sun X, Ke Y, Hou C.
Maternal smoking, consumption of alcohol, and caffeinated beverages during pregnancy and the risk of childhood brain tumors: a meta-analysis of observational studies.
BMC Public Health. 2024 May 6;24(1):1238. doi: 10.1186/s12889-024-18569-9. PMID: 38711042. Meta-analysis. ˍ




Xu C, Hou P, Li X, Xiao M, Zhang Z, Li Z, Xu J, Liu G, Tan Y, Fang C.
Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition.
Cancer Biol Med. 2024 May 6:j.issn.2095-3941.2023.0510. doi: 10.20892/j.issn.2095-3941.2023.0510. PMID: 38712813. Review. ˍ




de Zwart B, Ruis C.
An update on tests used for intraoperative monitoring of cognition during awake craniotomy.
Acta Neurochir (Wien). 2024 May 7;166(1):204. doi: 10.1007/s00701-024-06062-6. PMID: 38713405. Review. ˍ




Ghaznavi H, Afzalipour R, Khoei S, Sargazi S, Shirvalilou S, Sheervalilou R.
New insights into targeted therapy of glioblastoma using smart nanoparticles.
Cancer Cell Int. 2024 May 7;24(1):160. doi: 10.1186/s12935-024-03331-3. PMID: 38715021. Review. ˍ




Lan J, Liu Y, Chen J, Liu H, Feng Y, Liu J, Chen L.
Advanced tumor electric fields therapy: A review of innovative research and development and prospect of application in glioblastoma.
CNS Neurosci Ther. 2024 May 7;30(5):e14720. doi: 10.1111/cns.14720. PMID: 38715344. Review. ˍ




Lin C, Smith C, Rutka J.
Current immunotherapeutic approaches to diffuse intrinsic pontine glioma.
Front Genet. 2024 May 7;15:1349612. doi: 10.3389/fgene.2024.1349612. PMID: 38774284. Review. ˍ




Solomou G, Young AMH, Bulstrode HJCJ.
Microglia and macrophages in glioblastoma: landscapes and treatment directions.
Mol Oncol. 2024 May 7. doi: 10.1002/1878-0261.13657. PMID: 38712663. Review. ˍ




Wu J, Zhou Z, Wu Z, Tang Z, Li M, Yin S, Luo X, Wang L, Chen Y, Zhao G, Jiang T, Mao Y; National Glioma MDT Alliance of National Center for Neurological Diseases.
Consensuses of Chinese experts on Glioma multidisciplinary team management (2nd edition).
Chin Med J (Engl). 2024 May 7. doi: 10.1097/CM9.0000000000003129. PMID: 38712913. Guidelines. ˍ




Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y.
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
J Hematol Oncol. 2024 May 8;17(1):31. doi: 10.1186/s13045-024-01544-7. PMID: 38720342. Review. ˍ




Meena D, Jha S.
Autophagy in glioblastoma: A mechanistic perspective.
Int J Cancer. 2024 May 8. doi: 10.1002/ijc.34991. PMID: 38716809. Review˰ ˍ




Young CM, Viña-González A, de Toledo Aguiar RS, Kalman C, Pilitsis JG, Martin-Lopez LI, Mahani T, Pineda-Pardo JA.
A Scoping Review of Focused Ultrasound Enhanced Drug Delivery for Across the Blood-Brain Barrier for Brain Tumors.
Oper Neurosurg (Hagerstown). 2024 May 8. doi: 10.1227/ons.0000000000001175. PMID: 38717167.Review˰ ˍ




Bugakova AS, Chudakova DA, Myzina MS, Yanysheva EP, Ozerskaya IV, Soboleva AV, Baklaushev VP, Yusubalieva GM.
Non-Tumor Cells within the Tumor Microenvironment-The "Eminence Grise" of the Glioblastoma Pathogenesis and Potential Targets for Therapy.
Cells. 2024 May 9;13(10):808. doi: 10.3390/cells13100808. PMID: 38786032. Review. ˍ




*Lerouge L, Ruch A, Pierson J, Thomas N, Barberi-Heyob M.
Non-targeted effects of radiation therapy for glioblastoma.
Heliyon. 2024 May 9;10(10):e30813. doi: 10.1016/j.heliyon.2024.e30813. PMID: 38778925. Review. ˍ




No authors listed.
Glioma.
Nat Rev Dis Primers. 2024 May 9;10(1):34. doi: 10.1038/s41572-024-00524-y. PMID: 38724549. Primer. ˍ




Schaff LR, Ioannou M, Geurts M, van den Bent MJ, Mellinghoff IK, Schreck KC.
State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond.
Am Soc Clin Oncol Educ Book. 2024 May 9;44(3):e431450. doi: 10.1200/EDBK_431450. PMID: 38723228. Review. ˍ




Weller M, Wen PY, Chang SM, Dirven L, Lim M, Monje M, Reifenberger G.
Glioma.
Nat Rev Dis Primers. 2024 May 9;10(1):33. doi: 10.1038/s41572-024-00516-y. PMID: 38724526. Review˰ ˍ




Zedde M, Grisendi I, Assenza F, Napoli M, Moratti C, Di Cecco G, Pavone C, Bonacini L, D'Aniello S, Pezzella FR, Romano A, Pavesi G, Valzania F, Pascarella R.
Cerebellar mutism syndrome caused by bilateral cerebellar hemorrhage in adults: a case report and review of the literature.
Neurol Sci. 2024 May 9. doi: 10.1007/s10072-024-07571-z. PMID: 38724752. Case report; Review˰ ˍ




Koizumi S, Oishi T, Iwaizumi M, Kurozumi K.
Genomic medicine advances for brain tumors.
Int J Clin Oncol. 2024 May 10. doi: 10.1007/s10147-024-02522-2. PMID: 38727852. Review˰ ˍ




Mandorino M, Maitra A, Armenise D, Baldelli OM, Miciaccia M, Ferorelli S, Perrone MG, Scilimati A.
Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges.
Cancers (Basel). 2024 May 10;16(10):1814. doi: 10.3390/cancers16101814. PMID: 38791893. Review. ˍ




Montes-Escobar K, de la Hoz-M J, Castillo-Cordova P, Duran-Ospina JP, Bravo-Saltos RK, Lapo-Talledo GJ, Siteneski A.
Glioblastoma: a comprehensive approach combining bibliometric analysis, Latent Dirichlet Allocation, and HJ-Biplot : Glioblastoma insights and trends: a 49-year bibliometric analysis.
Neurosurg Rev. 2024 May 10;47(1):209. doi: 10.1007/s10143-024-02440-x. PMID: 38724684. Bibliometric analysis˰ ˍ




Wassef CE, Cain SA, Drummond KJ.
Changing practice to improve quality of life in glioma.
J Neurosurg. 2024 May 10:1-11. doi: 10.3171/2024.2.JNS221799. PMID: 38728762. Review˰ ˍ




Das S, Ahlawat S, Panda AK, Sarangi J, Jain P, Gupta RK, Vaishya S, Patir R.
Pediatric high grade gliomas: A comprehensive histopathological, immunohistochemical and molecular integrated approach in routine practice.
Pathol Res Pract. 2024 May 11;258:155347. doi: 10.1016/j.prp.2024.155347. PMID: 38763090. Review˰ ˍ




Habibi MA, Rashidi F, Gharedaghi H, Arshadi MR, Kazemivand S.
The safety and efficacy of bevacizumab in treatment of recurrent low-grade glioma: a systematic review and meta-analysis.
Eur J Clin Pharmacol. 2024 May 11. doi: 10.1007/s00228-024-03695-5. PMID: 38733390. Review; Meta-analysis˰ ˍ




Jensen MP, Qiang Z, Khan DZ, Stoyanov D, Baldeweg SE, Jaunmuktane Z, Brandner S, Marcus HJ.
Artificial intelligence in histopathological image analysis of central nervous system tumours: A systematic review.
Neuropathol Appl Neurobiol. 2024 May 13;50(3):e12981. doi: 10.1111/nan.12981. PMID: 38738494. Review; Recommendations. ˍ




Afshari AR, Sanati M, Ahmadi SS, Kesharwani P, Sahebkar A.
Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies.
Cancer Lett. 2024 May 14;593:216955. doi: 10.1016/j.canlet.2024.216955. PMID: 38750720. Review˰ ˍ




Cela I, Capone E, Trevisi G, Sala G.
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools.
Semin Cancer Biol. 2024 May 14;101:25-43. doi: 10.1016/j.semcancer.2024.04.003. PMID: 38754752. Review. ˍ




Liu YT, Chen YH, Chang CH, Liang HT.
Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature.
Neurooncol Adv. 2024 May 14;6(1):vdae072. doi: 10.1093/noajnl/vdae072. PMID: 38845691. Case report; Review. ˍ




O'Hare P, Cooney T, de Blank P, Gutmann DH, Kieran M, Milde T, Fangusaro J, Fisher M, Avula S, Packer R, Fukuoka K, Mankad K, Mueller S, Waanders AJ, Opocher E, Bouffet E, Raabe E, Werle NE, Azizi AA, Robison NJ, Hernáiz Driever P, Russo M, Schouten N, van Tilburg CM, Sehested A, Grill J, Bandopadhayay P, Kilday JP, Witt O, Ashley DM, Ertl-Wagner BB, Tabori U, Hargrave DR.
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition.
Neuro Oncol. 2024 May 14:noae074. doi: 10.1093/neuonc/noae074. PMID: 38743009. Guidelines. ˍ




Nwafor DC, Obiri-Yeboah D, Fazad F, Blanks W, Mut M.
Focused ultrasound as a treatment modality for gliomas.
Front Neurol. 2024 May 15;15:1387986. doi: 10.3389/fneur.2024.1387986. PMID: 38813245. Review. ˍ




Sanders JJ, Temin S, Ghoshal A, Alesi ER, Ali ZV, Chauhan C, Cleary JF, Epstein AS, Firn JI, Jones JA, Litzow MR, Lundquist D, Mardones MA, Nipp RD, Rabow MW, Rosa WE, Zimmermann C, Ferrell BR.
Palliative Care for Patients With Cancer: ASCO Guideline Update.
J Clin Oncol. 2024 May 15;42(19):2336-2357. doi: 10.1200/JCO.24.00542. PMID: 38748941. Guidelines. ˍ




Simon M, Hagemann A, Gajadin S, Signorelli F, Vincent AJPE; EANS Neuro-oncology Section.
Surgical treatment for insular gliomas. A systematic review and meta-analysis on behalf of the EANS neuro-oncology section.
Brain Spine. 2024 May 15;4:102828. doi: 10.1016/j.bas.2024.102828. PMID: 38859917. Review; Meta-analysis. ˍ











***